Immunotech Laboratories Inc (IMMB)

[Dodgeball]

That's where this gets confusing. IMMB claims 49% of Immunotech Laboratories BG and the license for ITV-1, and vigorously contests ENZCs claims.

Meanwhile, in the ENZC filings..

On March 26, 2018 an asset purchase agreement was entered with Immunotech Laboratories, Inc whereby the Exclusive License Agreement for the Patented Immunotherapy Treatment for the care of HIV/Aids and Hepatitis C patients, the Forty Nine Percent ownership in Immunotech Laboratories BG, all equipment and licensing of intellectual property associated with the Patented treatment in exchange for a secured note receivable, common stock of Enzolytics, Inc. issued to Immunotech Laboratories, Inc. and assumption of certain debt from Immunotech by Enzolytics, Inc.

However, (unless I missed something) nothing in the most recent ENZC filings indicate the purchase agreement was ever completed. And if the transaction did go to fruition, how much ENZC stock does IMMB now own?

Moreover, as far as I can tell, the brand new ENZC website appears to have removed the claim of 49% ownership in Immunotech.

Two highly conflicting claims. Which is true?